Net profit of Mankind Pharma rose 31.75% to Rs 554.35 crore in the quarter ended March 2026 as against Rs 420.77 crore during the previous quarter ended March 2025. Sales rose 11.81% to Rs 3442.93 crore in the quarter ended March 2026 as against Rs 3079.37 crore during the previous quarter ended March 2025.
For the full year,net profit declined 3.92% to Rs 1912.93 crore in the year ended March 2026 as against Rs 1990.96 crore during the previous year ended March 2025. Sales rose 16.96% to Rs 14277.64 crore in the year ended March 2026 as against Rs 12207.44 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 3442.93 | 3079.37 | 12 | 14277.64 | 12207.44 | 17 |
| OPM % | 27.01 | 22.19 | - | 25.34 | 24.72 | - |
| PBDT | 905.41 | 746.30 | 21 | 3348.61 | 3137.55 | 7 |
| PBT | 682.33 | 515.43 | 32 | 2462.43 | 2516.33 | -2 |
| NP | 554.35 | 420.77 | 32 | 1912.93 | 1990.96 | -4 |
Powered by Capital Market - Live News